申请人:E. R. Squibb & Sons, Inc.
公开号:US04604407A1
公开(公告)日:1986-08-05
Hydroxamates are provided having the structure ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, aryl, lower alkenyl, cycloalkenyl, aralkyl, or ##STR2## wherein n is 1 to 4 and X is hydroxy, alkoxy, amino, C.sub.1 -C.sub.4 -alkylamino or C.sub.1 -C.sub.4 -dialkylamino. R.sup.2 is hydrogen or lower alkyl; and R.sup.3 is C.sub.1 -C.sub.20 alkyl or C.sub.3 -C.sub.20 alkenyl, aryl, aryl-alkyl, cycloalkyl, aryl-alkenyl, lower alkoxy, lower alkenyloxy, aryl-alkoxy or cycloalkyloxy, and m is 0 to 5. These compounds are useful as inhibitors of .DELTA..sup.5 -lipoxygenase and as such are useful as antiallergy agents.
提供具有以下结构的羟胺酸酯:##STR1## 其中 R.sup.1 是氢、较低烷基、芳基、较低烯基、环烯基、芳基烷基,或 ##STR2## 其中 n 为1至4,X 为羟基、烷氧基、氨基、C.sub.1 -C.sub.4 -烷基氨基或C.sub.1 -C.sub.4 -二烷基氨基。R.sup.2 是氢或较低烷基;R.sup.3 是C.sub.1 -C.sub.20 烷基或C.sub.3 -C.sub.20 烯基、芳基、芳基烷基、环烷基、芳基烯基、较低烷氧基、较低烯氧基、芳基烷氧基或环烷氧基,m 为0至5。这些化合物可用作.DELTA..sup.5-脂氧合酶的抑制剂,因此可用作抗过敏药物。